The a2 Milk Company Limited
The a2 Milk Company Limited (ACOPF) Stock Competitors & Peer Comparison
See (ACOPF) competitors and their performances in Stock Market.
Peer Comparison Table: Packaged Foods Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACOPF | $5.52 | -1.65% | 4B | 34.50 | $0.16 | +0.89% |
| UVRBY | $14.18 | +0.00% | 249.8B | 15.58 | $0.91 | +4.91% |
| NSRGY | $94.24 | +0.67% | 244.4B | 19.04 | $4.95 | +3.60% |
| NSRGF | $94.64 | +0.39% | 239.4B | 19.08 | $4.96 | +3.90% |
| GPDNF | $86.70 | +1.25% | 56B | 26.19 | $3.31 | +2.81% |
| DANOY | $17.16 | +0.06% | 55.5B | 26.02 | $0.66 | +2.74% |
| JBSAY | $13.81 | +3.06% | 30.6B | 6.94 | $1.99 | +14.81% |
| AJINF | $26.94 | -0.99% | 26.4B | 112.25 | $0.24 | +1.02% |
| ASBFY | $31.75 | +0.13% | 23.4B | 13.26 | $2.39 | +3.73% |
| ASBFF | $29.71 | +0.00% | 21.2B | 12.43 | $2.39 | +3.89% |
Stock Comparison
ACOPF vs UVRBY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, UVRBY has a market cap of 249.8B. Regarding current trading prices, ACOPF is priced at $5.52, while UVRBY trades at $14.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas UVRBY's P/E ratio is 15.58. In terms of profitability, ACOPF's ROE is +0.14%, compared to UVRBY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to UVRBY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check UVRBY's competition here
ACOPF vs NSRGY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NSRGY has a market cap of 244.4B. Regarding current trading prices, ACOPF is priced at $5.52, while NSRGY trades at $94.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NSRGY's P/E ratio is 19.04. In terms of profitability, ACOPF's ROE is +0.14%, compared to NSRGY's ROE of +0.32%. Regarding short-term risk, ACOPF is less volatile compared to NSRGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSRGY's competition here
ACOPF vs NSRGF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NSRGF has a market cap of 239.4B. Regarding current trading prices, ACOPF is priced at $5.52, while NSRGF trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NSRGF's P/E ratio is 19.08. In terms of profitability, ACOPF's ROE is +0.14%, compared to NSRGF's ROE of +0.32%. Regarding short-term risk, ACOPF is less volatile compared to NSRGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSRGF's competition here
ACOPF vs GPDNF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GPDNF has a market cap of 56B. Regarding current trading prices, ACOPF is priced at $5.52, while GPDNF trades at $86.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GPDNF's P/E ratio is 26.19. In terms of profitability, ACOPF's ROE is +0.14%, compared to GPDNF's ROE of +0.12%. Regarding short-term risk, ACOPF is less volatile compared to GPDNF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GPDNF's competition here
ACOPF vs DANOY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, DANOY has a market cap of 55.5B. Regarding current trading prices, ACOPF is priced at $5.52, while DANOY trades at $17.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas DANOY's P/E ratio is 26.02. In terms of profitability, ACOPF's ROE is +0.14%, compared to DANOY's ROE of +0.12%. Regarding short-term risk, ACOPF is less volatile compared to DANOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check DANOY's competition here
ACOPF vs JBSAY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, JBSAY has a market cap of 30.6B. Regarding current trading prices, ACOPF is priced at $5.52, while JBSAY trades at $13.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas JBSAY's P/E ratio is 6.94. In terms of profitability, ACOPF's ROE is +0.14%, compared to JBSAY's ROE of +0.25%. Regarding short-term risk, ACOPF is less volatile compared to JBSAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check JBSAY's competition here
ACOPF vs AJINF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, AJINF has a market cap of 26.4B. Regarding current trading prices, ACOPF is priced at $5.52, while AJINF trades at $26.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas AJINF's P/E ratio is 112.25. In terms of profitability, ACOPF's ROE is +0.14%, compared to AJINF's ROE of +0.09%. Regarding short-term risk, ACOPF and AJINF have similar daily volatility (0.00).Check AJINF's competition here
ACOPF vs ASBFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ASBFY has a market cap of 23.4B. Regarding current trading prices, ACOPF is priced at $5.52, while ASBFY trades at $31.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ASBFY's P/E ratio is 13.26. In terms of profitability, ACOPF's ROE is +0.14%, compared to ASBFY's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to ASBFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ASBFY's competition here
ACOPF vs ASBFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ASBFF has a market cap of 21.2B. Regarding current trading prices, ACOPF is priced at $5.52, while ASBFF trades at $29.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ASBFF's P/E ratio is 12.43. In terms of profitability, ACOPF's ROE is +0.14%, compared to ASBFF's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to ASBFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ASBFF's competition here
ACOPF vs KRYAF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, KRYAF has a market cap of 16.8B. Regarding current trading prices, ACOPF is priced at $5.52, while KRYAF trades at $103.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas KRYAF's P/E ratio is 21.31. In terms of profitability, ACOPF's ROE is +0.14%, compared to KRYAF's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to KRYAF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check KRYAF's competition here
ACOPF vs KRYAY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, KRYAY has a market cap of 16B. Regarding current trading prices, ACOPF is priced at $5.52, while KRYAY trades at $94.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas KRYAY's P/E ratio is 19.56. In terms of profitability, ACOPF's ROE is +0.14%, compared to KRYAY's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to KRYAY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check KRYAY's competition here
ACOPF vs WHGRF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, WHGRF has a market cap of 14.6B. Regarding current trading prices, ACOPF is priced at $5.52, while WHGRF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas WHGRF's P/E ratio is 8.74. In terms of profitability, ACOPF's ROE is +0.14%, compared to WHGRF's ROE of +0.08%. Regarding short-term risk, ACOPF is less volatile compared to WHGRF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check WHGRF's competition here
ACOPF vs JDEPF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, JDEPF has a market cap of 14.1B. Regarding current trading prices, ACOPF is priced at $5.52, while JDEPF trades at $28.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas JDEPF's P/E ratio is 20.26. In terms of profitability, ACOPF's ROE is +0.14%, compared to JDEPF's ROE of +0.05%. Regarding short-term risk, ACOPF is less volatile compared to JDEPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check JDEPF's competition here
ACOPF vs AJINY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, AJINY has a market cap of 14B. Regarding current trading prices, ACOPF is priced at $5.52, while AJINY trades at $27.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas AJINY's P/E ratio is 114.73. In terms of profitability, ACOPF's ROE is +0.14%, compared to AJINY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to AJINY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check AJINY's competition here
ACOPF vs WHGLY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, WHGLY has a market cap of 13.8B. Regarding current trading prices, ACOPF is priced at $5.52, while WHGLY trades at $21.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas WHGLY's P/E ratio is 8.51. In terms of profitability, ACOPF's ROE is +0.14%, compared to WHGLY's ROE of +0.08%. Regarding short-term risk, ACOPF is less volatile compared to WHGLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check WHGLY's competition here
ACOPF vs BMBOY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, BMBOY has a market cap of 13.4B. Regarding current trading prices, ACOPF is priced at $5.52, while BMBOY trades at $12.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas BMBOY's P/E ratio is 21.75. In terms of profitability, ACOPF's ROE is +0.14%, compared to BMBOY's ROE of +0.09%. Regarding short-term risk, ACOPF and BMBOY have similar daily volatility (0.00).Check BMBOY's competition here
ACOPF vs GRBMF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GRBMF has a market cap of 12.9B. Regarding current trading prices, ACOPF is priced at $5.52, while GRBMF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GRBMF's P/E ratio is 20.71. In terms of profitability, ACOPF's ROE is +0.14%, compared to GRBMF's ROE of +0.09%. Regarding short-term risk, ACOPF and GRBMF have similar daily volatility (0.00).Check GRBMF's competition here
ACOPF vs ORKLY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ORKLY has a market cap of 11.4B. Regarding current trading prices, ACOPF is priced at $5.52, while ORKLY trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ORKLY's P/E ratio is 19.76. In terms of profitability, ACOPF's ROE is +0.14%, compared to ORKLY's ROE of +0.23%. Regarding short-term risk, ACOPF is less volatile compared to ORKLY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ORKLY's competition here
ACOPF vs ORKLF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ORKLF has a market cap of 11B. Regarding current trading prices, ACOPF is priced at $5.52, while ORKLF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ORKLF's P/E ratio is 18.97. In terms of profitability, ACOPF's ROE is +0.14%, compared to ORKLF's ROE of +0.23%. Regarding short-term risk, ACOPF and ORKLF have similar daily volatility (0.00).Check ORKLF's competition here
ACOPF vs SAPIF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SAPIF has a market cap of 10.1B. Regarding current trading prices, ACOPF is priced at $5.52, while SAPIF trades at $24.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SAPIF's P/E ratio is -98.44. In terms of profitability, ACOPF's ROE is +0.14%, compared to SAPIF's ROE of -0.02%. Regarding short-term risk, ACOPF is less volatile compared to SAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check SAPIF's competition here
ACOPF vs BRZL Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, BRZL has a market cap of 10.1B. Regarding current trading prices, ACOPF is priced at $5.52, while BRZL trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas BRZL's P/E ratio is N/A. In terms of profitability, ACOPF's ROE is +0.14%, compared to BRZL's ROE of +0.91%. Regarding short-term risk, ACOPF is less volatile compared to BRZL. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check BRZL's competition here
ACOPF vs CIADF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CIADF has a market cap of 9.7B. Regarding current trading prices, ACOPF is priced at $5.52, while CIADF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CIADF's P/E ratio is 16.67. In terms of profitability, ACOPF's ROE is +0.14%, compared to CIADF's ROE of +0.00%. Regarding short-term risk, ACOPF and CIADF have similar daily volatility (0.00).Check CIADF's competition here
ACOPF vs KIKOY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, KIKOY has a market cap of 9B. Regarding current trading prices, ACOPF is priced at $5.52, while KIKOY trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas KIKOY's P/E ratio is 21.59. In terms of profitability, ACOPF's ROE is +0.14%, compared to KIKOY's ROE of +0.12%. Regarding short-term risk, ACOPF and KIKOY have similar daily volatility (0.00).Check KIKOY's competition here
ACOPF vs TTAZF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TTAZF has a market cap of 8.8B. Regarding current trading prices, ACOPF is priced at $5.52, while TTAZF trades at $7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TTAZF's P/E ratio is 77.60. In terms of profitability, ACOPF's ROE is +0.14%, compared to TTAZF's ROE of N/A. Regarding short-term risk, ACOPF and TTAZF have similar daily volatility (0.00).Check TTAZF's competition here
ACOPF vs PIFFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PIFFY has a market cap of 8.5B. Regarding current trading prices, ACOPF is priced at $5.52, while PIFFY trades at $14.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PIFFY's P/E ratio is 19.86. In terms of profitability, ACOPF's ROE is +0.14%, compared to PIFFY's ROE of +0.19%. Regarding short-term risk, ACOPF is less volatile compared to PIFFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check PIFFY's competition here
ACOPF vs WWNTF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, WWNTF has a market cap of 8.4B. Regarding current trading prices, ACOPF is priced at $5.52, while WWNTF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas WWNTF's P/E ratio is 14.20. In terms of profitability, ACOPF's ROE is +0.14%, compared to WWNTF's ROE of +0.18%. Regarding short-term risk, ACOPF is less volatile compared to WWNTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check WWNTF's competition here
ACOPF vs CIADY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CIADY has a market cap of 8.2B. Regarding current trading prices, ACOPF is priced at $5.52, while CIADY trades at $21.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CIADY's P/E ratio is 520.80. In terms of profitability, ACOPF's ROE is +0.14%, compared to CIADY's ROE of +0.00%. Regarding short-term risk, ACOPF is less volatile compared to CIADY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CIADY's competition here
ACOPF vs TCYMF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TCYMF has a market cap of 8.1B. Regarding current trading prices, ACOPF is priced at $5.52, while TCYMF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TCYMF's P/E ratio is 14.40. In terms of profitability, ACOPF's ROE is +0.14%, compared to TCYMF's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to TCYMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TCYMF's competition here
ACOPF vs TYCMY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TYCMY has a market cap of 8.1B. Regarding current trading prices, ACOPF is priced at $5.52, while TYCMY trades at $28.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TYCMY's P/E ratio is 14.05. In terms of profitability, ACOPF's ROE is +0.14%, compared to TYCMY's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to TYCMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TYCMY's competition here
ACOPF vs KIKOF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, KIKOF has a market cap of 7.9B. Regarding current trading prices, ACOPF is priced at $5.52, while KIKOF trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas KIKOF's P/E ratio is 19.18. In terms of profitability, ACOPF's ROE is +0.14%, compared to KIKOF's ROE of +0.12%. Regarding short-term risk, ACOPF and KIKOF have similar daily volatility (0.00).Check KIKOF's competition here
ACOPF vs LOTBY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, LOTBY has a market cap of 7.8B. Regarding current trading prices, ACOPF is priced at $5.52, while LOTBY trades at $96.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas LOTBY's P/E ratio is 42.18. In terms of profitability, ACOPF's ROE is +0.14%, compared to LOTBY's ROE of +0.21%. Regarding short-term risk, ACOPF and LOTBY have similar daily volatility (0.00).Check LOTBY's competition here
ACOPF vs TSUKY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TSUKY has a market cap of 7.5B. Regarding current trading prices, ACOPF is priced at $5.52, while TSUKY trades at $72.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TSUKY's P/E ratio is 17.20. In terms of profitability, ACOPF's ROE is +0.14%, compared to TSUKY's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to TSUKY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TSUKY's competition here
ACOPF vs TATYY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TATYY has a market cap of 7.1B. Regarding current trading prices, ACOPF is priced at $5.52, while TATYY trades at $29.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TATYY's P/E ratio is 47.21. In terms of profitability, ACOPF's ROE is +0.14%, compared to TATYY's ROE of +0.18%. Regarding short-term risk, ACOPF is less volatile compared to TATYY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TATYY's competition here
ACOPF vs SDPNF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SDPNF has a market cap of 6.9B. Regarding current trading prices, ACOPF is priced at $5.52, while SDPNF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SDPNF's P/E ratio is 11.11. In terms of profitability, ACOPF's ROE is +0.14%, compared to SDPNF's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to SDPNF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check SDPNF's competition here
ACOPF vs ARHUF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ARHUF has a market cap of 6.8B. Regarding current trading prices, ACOPF is priced at $5.52, while ARHUF trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ARHUF's P/E ratio is 19.60. In terms of profitability, ACOPF's ROE is +0.14%, compared to ARHUF's ROE of +0.18%. Regarding short-term risk, ACOPF is less volatile compared to ARHUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ARHUF's competition here
ACOPF vs DLLFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, DLLFF has a market cap of 6.5B. Regarding current trading prices, ACOPF is priced at $5.52, while DLLFF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas DLLFF's P/E ratio is 14.00. In terms of profitability, ACOPF's ROE is +0.14%, compared to DLLFF's ROE of N/A. Regarding short-term risk, ACOPF and DLLFF have similar daily volatility (0.00).Check DLLFF's competition here
ACOPF vs GCHOY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GCHOY has a market cap of 6.5B. Regarding current trading prices, ACOPF is priced at $5.52, while GCHOY trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GCHOY's P/E ratio is 27.31. In terms of profitability, ACOPF's ROE is +0.14%, compared to GCHOY's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to GCHOY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GCHOY's competition here
ACOPF vs GPAGF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GPAGF has a market cap of 6.4B. Regarding current trading prices, ACOPF is priced at $5.52, while GPAGF trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GPAGF's P/E ratio is 11.53. In terms of profitability, ACOPF's ROE is +0.14%, compared to GPAGF's ROE of +0.27%. Regarding short-term risk, ACOPF is less volatile compared to GPAGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GPAGF's competition here
ACOPF vs TSUKF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TSUKF has a market cap of 6.2B. Regarding current trading prices, ACOPF is priced at $5.52, while TSUKF trades at $62.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TSUKF's P/E ratio is 15.97. In terms of profitability, ACOPF's ROE is +0.14%, compared to TSUKF's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to TSUKF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TSUKF's competition here
ACOPF vs MEJHY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, MEJHY has a market cap of 5.7B. Regarding current trading prices, ACOPF is priced at $5.52, while MEJHY trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas MEJHY's P/E ratio is 16.76. In terms of profitability, ACOPF's ROE is +0.14%, compared to MEJHY's ROE of +0.07%. Regarding short-term risk, ACOPF is less volatile compared to MEJHY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check MEJHY's competition here
ACOPF vs MEJHF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, MEJHF has a market cap of 5.5B. Regarding current trading prices, ACOPF is priced at $5.52, while MEJHF trades at $20.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas MEJHF's P/E ratio is 17.02. In terms of profitability, ACOPF's ROE is +0.14%, compared to MEJHF's ROE of +0.03%. Regarding short-term risk, ACOPF is less volatile compared to MEJHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check MEJHF's competition here
ACOPF vs NFPDF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NFPDF has a market cap of 5.5B. Regarding current trading prices, ACOPF is priced at $5.52, while NFPDF trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NFPDF's P/E ratio is 15.18. In terms of profitability, ACOPF's ROE is +0.14%, compared to NFPDF's ROE of +0.11%. Regarding short-term risk, ACOPF and NFPDF have similar daily volatility (0.00).Check NFPDF's competition here
ACOPF vs EMLZF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, EMLZF has a market cap of 5.4B. Regarding current trading prices, ACOPF is priced at $5.52, while EMLZF trades at $1,007.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas EMLZF's P/E ratio is 19.76. In terms of profitability, ACOPF's ROE is +0.14%, compared to EMLZF's ROE of +0.19%. Regarding short-term risk, ACOPF is less volatile compared to EMLZF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check EMLZF's competition here
ACOPF vs CFEIY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CFEIY has a market cap of 5.4B. Regarding current trading prices, ACOPF is priced at $5.52, while CFEIY trades at $5.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CFEIY's P/E ratio is 10.95. In terms of profitability, ACOPF's ROE is +0.14%, compared to CFEIY's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to CFEIY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CFEIY's competition here
ACOPF vs SMPFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SMPFF has a market cap of 5.2B. Regarding current trading prices, ACOPF is priced at $5.52, while SMPFF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SMPFF's P/E ratio is 13.38. In terms of profitability, ACOPF's ROE is +0.14%, compared to SMPFF's ROE of +0.24%. Regarding short-term risk, ACOPF and SMPFF have similar daily volatility (0.00).Check SMPFF's competition here
ACOPF vs CHFLF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CHFLF has a market cap of 4.9B. Regarding current trading prices, ACOPF is priced at $5.52, while CHFLF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CHFLF's P/E ratio is 10.90. In terms of profitability, ACOPF's ROE is +0.14%, compared to CHFLF's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to CHFLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CHFLF's competition here
ACOPF vs IOIOF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, IOIOF has a market cap of 4.7B. Regarding current trading prices, ACOPF is priced at $5.52, while IOIOF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas IOIOF's P/E ratio is 12.64. In terms of profitability, ACOPF's ROE is +0.14%, compared to IOIOF's ROE of +0.12%. Regarding short-term risk, ACOPF and IOIOF have similar daily volatility (0.00).Check IOIOF's competition here
ACOPF vs PIFMY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PIFMY has a market cap of 4.3B. Regarding current trading prices, ACOPF is priced at $5.52, while PIFMY trades at $24.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PIFMY's P/E ratio is 6.63. In terms of profitability, ACOPF's ROE is +0.14%, compared to PIFMY's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to PIFMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check PIFMY's competition here
ACOPF vs GLAPY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GLAPY has a market cap of 4.2B. Regarding current trading prices, ACOPF is priced at $5.52, while GLAPY trades at $81.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GLAPY's P/E ratio is 34.88. In terms of profitability, ACOPF's ROE is +0.14%, compared to GLAPY's ROE of +0.08%. Regarding short-term risk, ACOPF is less volatile compared to GLAPY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GLAPY's competition here
ACOPF vs NSLYF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NSLYF has a market cap of 4.2B. Regarding current trading prices, ACOPF is priced at $5.52, while NSLYF trades at $17.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NSLYF's P/E ratio is 44.87. In terms of profitability, ACOPF's ROE is +0.14%, compared to NSLYF's ROE of +0.70%. Regarding short-term risk, ACOPF is less volatile compared to NSLYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSLYF's competition here
ACOPF vs PIFMF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PIFMF has a market cap of 4.1B. Regarding current trading prices, ACOPF is priced at $5.52, while PIFMF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PIFMF's P/E ratio is 7.83. In terms of profitability, ACOPF's ROE is +0.14%, compared to PIFMF's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to PIFMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check PIFMF's competition here
ACOPF vs GLAPF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GLAPF has a market cap of 3.7B. Regarding current trading prices, ACOPF is priced at $5.52, while GLAPF trades at $14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GLAPF's P/E ratio is 31.02. In terms of profitability, ACOPF's ROE is +0.14%, compared to GLAPF's ROE of +0.11%. Regarding short-term risk, ACOPF is less volatile compared to GLAPF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GLAPF's competition here
ACOPF vs YMZBY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, YMZBY has a market cap of 3.6B. Regarding current trading prices, ACOPF is priced at $5.52, while YMZBY trades at $180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas YMZBY's P/E ratio is 14.08. In terms of profitability, ACOPF's ROE is +0.14%, compared to YMZBY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to YMZBY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check YMZBY's competition here
ACOPF vs FPAFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FPAFY has a market cap of 3.5B. Regarding current trading prices, ACOPF is priced at $5.52, while FPAFY trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FPAFY's P/E ratio is 5.85. In terms of profitability, ACOPF's ROE is +0.14%, compared to FPAFY's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to FPAFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FPAFY's competition here
ACOPF vs FPAFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FPAFF has a market cap of 3.5B. Regarding current trading prices, ACOPF is priced at $5.52, while FPAFF trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FPAFF's P/E ratio is 5.91. In terms of profitability, ACOPF's ROE is +0.14%, compared to FPAFF's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to FPAFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FPAFF's competition here
ACOPF vs NIPMY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NIPMY has a market cap of 3.5B. Regarding current trading prices, ACOPF is priced at $5.52, while NIPMY trades at $17.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NIPMY's P/E ratio is 18.68. In terms of profitability, ACOPF's ROE is +0.14%, compared to NIPMY's ROE of +0.05%. Regarding short-term risk, ACOPF is less volatile compared to NIPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NIPMY's competition here
ACOPF vs MRRTY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, MRRTY has a market cap of 3.4B. Regarding current trading prices, ACOPF is priced at $5.52, while MRRTY trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas MRRTY's P/E ratio is 13.50. In terms of profitability, ACOPF's ROE is +0.14%, compared to MRRTY's ROE of +0.68%. Regarding short-term risk, ACOPF is less volatile compared to MRRTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check MRRTY's competition here
ACOPF vs CRWKF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CRWKF has a market cap of 3.4B. Regarding current trading prices, ACOPF is priced at $5.52, while CRWKF trades at $63.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CRWKF's P/E ratio is 23.79. In terms of profitability, ACOPF's ROE is +0.14%, compared to CRWKF's ROE of +0.14%. Regarding short-term risk, ACOPF is less volatile compared to CRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CRWKF's competition here
ACOPF vs NSFMF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NSFMF has a market cap of 3.3B. Regarding current trading prices, ACOPF is priced at $5.52, while NSFMF trades at $11.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NSFMF's P/E ratio is 14.20. In terms of profitability, ACOPF's ROE is +0.14%, compared to NSFMF's ROE of +0.07%. Regarding short-term risk, ACOPF is less volatile compared to NSFMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NSFMF's competition here
ACOPF vs NHFOF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NHFOF has a market cap of 3.3B. Regarding current trading prices, ACOPF is priced at $5.52, while NHFOF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NHFOF's P/E ratio is 18.54. In terms of profitability, ACOPF's ROE is +0.14%, compared to NHFOF's ROE of +0.05%. Regarding short-term risk, ACOPF is less volatile compared to NHFOF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NHFOF's competition here
ACOPF vs UVRBF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, UVRBF has a market cap of 3.2B. Regarding current trading prices, ACOPF is priced at $5.52, while UVRBF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas UVRBF's P/E ratio is 16.67. In terms of profitability, ACOPF's ROE is +0.14%, compared to UVRBF's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to UVRBF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check UVRBF's competition here
ACOPF vs MLFNF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, MLFNF has a market cap of 3.2B. Regarding current trading prices, ACOPF is priced at $5.52, while MLFNF trades at $25.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas MLFNF's P/E ratio is 24.64. In terms of profitability, ACOPF's ROE is +0.14%, compared to MLFNF's ROE of +0.12%. Regarding short-term risk, ACOPF and MLFNF have similar daily volatility (0.00).Check MLFNF's competition here
ACOPF vs PRBZF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PRBZF has a market cap of 3.1B. Regarding current trading prices, ACOPF is priced at $5.52, while PRBZF trades at $69.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PRBZF's P/E ratio is 46.02. In terms of profitability, ACOPF's ROE is +0.14%, compared to PRBZF's ROE of +0.05%. Regarding short-term risk, ACOPF and PRBZF have similar daily volatility (0.00).Check PRBZF's competition here
ACOPF vs TATYF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TATYF has a market cap of 3.1B. Regarding current trading prices, ACOPF is priced at $5.52, while TATYF trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TATYF's P/E ratio is 43.44. In terms of profitability, ACOPF's ROE is +0.14%, compared to TATYF's ROE of +0.18%. Regarding short-term risk, ACOPF is less volatile compared to TATYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TATYF's competition here
ACOPF vs NCHEY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NCHEY has a market cap of 3.1B. Regarding current trading prices, ACOPF is priced at $5.52, while NCHEY trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NCHEY's P/E ratio is 18.06. In terms of profitability, ACOPF's ROE is +0.14%, compared to NCHEY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to NCHEY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NCHEY's competition here
ACOPF vs CBCFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CBCFF has a market cap of 2.9B. Regarding current trading prices, ACOPF is priced at $5.52, while CBCFF trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CBCFF's P/E ratio is 21.90. In terms of profitability, ACOPF's ROE is +0.14%, compared to CBCFF's ROE of +0.10%. Regarding short-term risk, ACOPF is less volatile compared to CBCFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check CBCFF's competition here
ACOPF vs LYSFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, LYSFF has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $5.52, while LYSFF trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas LYSFF's P/E ratio is 22.62. In terms of profitability, ACOPF's ROE is +0.14%, compared to LYSFF's ROE of +0.10%. Regarding short-term risk, ACOPF is less volatile compared to LYSFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check LYSFF's competition here
ACOPF vs LYSFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, LYSFY has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $5.52, while LYSFY trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas LYSFY's P/E ratio is 15.93. In terms of profitability, ACOPF's ROE is +0.14%, compared to LYSFY's ROE of +0.10%. Regarding short-term risk, ACOPF is less volatile compared to LYSFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check LYSFY's competition here
ACOPF vs EBRPY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, EBRPY has a market cap of 2.8B. Regarding current trading prices, ACOPF is priced at $5.52, while EBRPY trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas EBRPY's P/E ratio is 20.34. In terms of profitability, ACOPF's ROE is +0.14%, compared to EBRPY's ROE of +0.06%. Regarding short-term risk, ACOPF and EBRPY have similar daily volatility (0.00).Check EBRPY's competition here
ACOPF vs EBRPF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, EBRPF has a market cap of 2.7B. Regarding current trading prices, ACOPF is priced at $5.52, while EBRPF trades at $17.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas EBRPF's P/E ratio is 15.72. In terms of profitability, ACOPF's ROE is +0.14%, compared to EBRPF's ROE of +0.05%. Regarding short-term risk, ACOPF and EBRPF have similar daily volatility (0.00).Check EBRPF's competition here
ACOPF vs TBLMF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TBLMF has a market cap of 2.7B. Regarding current trading prices, ACOPF is priced at $5.52, while TBLMF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TBLMF's P/E ratio is 12.77. In terms of profitability, ACOPF's ROE is +0.14%, compared to TBLMF's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to TBLMF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TBLMF's competition here
ACOPF vs SUEZF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SUEZF has a market cap of 2.7B. Regarding current trading prices, ACOPF is priced at $5.52, while SUEZF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SUEZF's P/E ratio is -10.32. In terms of profitability, ACOPF's ROE is +0.14%, compared to SUEZF's ROE of -0.06%. Regarding short-term risk, ACOPF and SUEZF have similar daily volatility (0.00).Check SUEZF's competition here
ACOPF vs ARZTF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, ARZTF has a market cap of 2.5B. Regarding current trading prices, ACOPF is priced at $5.52, while ARZTF trades at $82.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas ARZTF's P/E ratio is 690.00. In terms of profitability, ACOPF's ROE is +0.14%, compared to ARZTF's ROE of +0.22%. Regarding short-term risk, ACOPF is less volatile compared to ARZTF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check ARZTF's competition here
ACOPF vs SUEZY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SUEZY has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $5.52, while SUEZY trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SUEZY's P/E ratio is -9.37. In terms of profitability, ACOPF's ROE is +0.14%, compared to SUEZY's ROE of -0.06%. Regarding short-term risk, ACOPF and SUEZY have similar daily volatility (0.00).Check SUEZY's competition here
ACOPF vs PFODF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PFODF has a market cap of 2.4B. Regarding current trading prices, ACOPF is priced at $5.52, while PFODF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PFODF's P/E ratio is 14.47. In terms of profitability, ACOPF's ROE is +0.14%, compared to PFODF's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to PFODF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check PFODF's competition here
ACOPF vs PRRFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, PRRFY has a market cap of 2.3B. Regarding current trading prices, ACOPF is priced at $5.52, while PRRFY trades at $13.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas PRRFY's P/E ratio is 13.96. In terms of profitability, ACOPF's ROE is +0.14%, compared to PRRFY's ROE of +0.08%. Regarding short-term risk, ACOPF and PRRFY have similar daily volatility (0.00).Check PRRFY's competition here
ACOPF vs CLBEY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, CLBEY has a market cap of 2.2B. Regarding current trading prices, ACOPF is priced at $5.52, while CLBEY trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas CLBEY's P/E ratio is 16.04. In terms of profitability, ACOPF's ROE is +0.14%, compared to CLBEY's ROE of +0.10%. Regarding short-term risk, ACOPF and CLBEY have similar daily volatility (0.00).Check CLBEY's competition here
ACOPF vs SGLJF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, SGLJF has a market cap of 2.2B. Regarding current trading prices, ACOPF is priced at $5.52, while SGLJF trades at $15.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas SGLJF's P/E ratio is 20.05. In terms of profitability, ACOPF's ROE is +0.14%, compared to SGLJF's ROE of +0.21%. Regarding short-term risk, ACOPF is less volatile compared to SGLJF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check SGLJF's competition here
ACOPF vs GRPBF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GRPBF has a market cap of 2.1B. Regarding current trading prices, ACOPF is priced at $5.52, while GRPBF trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GRPBF's P/E ratio is N/A. In terms of profitability, ACOPF's ROE is +0.14%, compared to GRPBF's ROE of N/A. Regarding short-term risk, ACOPF and GRPBF have similar daily volatility (0.00).Check GRPBF's competition here
ACOPF vs FTROF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FTROF has a market cap of 1.9B. Regarding current trading prices, ACOPF is priced at $5.52, while FTROF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FTROF's P/E ratio is 7.62. In terms of profitability, ACOPF's ROE is +0.14%, compared to FTROF's ROE of +0.08%. Regarding short-term risk, ACOPF is less volatile compared to FTROF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FTROF's competition here
ACOPF vs HOFJF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, HOFJF has a market cap of 1.8B. Regarding current trading prices, ACOPF is priced at $5.52, while HOFJF trades at $19.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas HOFJF's P/E ratio is 23.90. In terms of profitability, ACOPF's ROE is +0.14%, compared to HOFJF's ROE of +0.04%. Regarding short-term risk, ACOPF is less volatile compared to HOFJF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check HOFJF's competition here
ACOPF vs TBLMY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TBLMY has a market cap of 1.7B. Regarding current trading prices, ACOPF is priced at $5.52, while TBLMY trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TBLMY's P/E ratio is 12.02. In terms of profitability, ACOPF's ROE is +0.14%, compared to TBLMY's ROE of +0.17%. Regarding short-term risk, ACOPF and TBLMY have similar daily volatility (0.00).Check TBLMY's competition here
ACOPF vs FSRCY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FSRCY has a market cap of 1.7B. Regarding current trading prices, ACOPF is priced at $5.52, while FSRCY trades at $109.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FSRCY's P/E ratio is 9.57. In terms of profitability, ACOPF's ROE is +0.14%, compared to FSRCY's ROE of +0.08%. Regarding short-term risk, ACOPF is less volatile compared to FSRCY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FSRCY's competition here
ACOPF vs AVSFY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, AVSFY has a market cap of 1.7B. Regarding current trading prices, ACOPF is priced at $5.52, while AVSFY trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas AVSFY's P/E ratio is 12.50. In terms of profitability, ACOPF's ROE is +0.14%, compared to AVSFY's ROE of +0.41%. Regarding short-term risk, ACOPF is less volatile compared to AVSFY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check AVSFY's competition here
ACOPF vs YNNHF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, YNNHF has a market cap of 1.6B. Regarding current trading prices, ACOPF is priced at $5.52, while YNNHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas YNNHF's P/E ratio is 15.45. In terms of profitability, ACOPF's ROE is +0.14%, compared to YNNHF's ROE of +0.16%. Regarding short-term risk, ACOPF is less volatile compared to YNNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check YNNHF's competition here
ACOPF vs GNCGY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GNCGY has a market cap of 1.5B. Regarding current trading prices, ACOPF is priced at $5.52, while GNCGY trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GNCGY's P/E ratio is 0.26. In terms of profitability, ACOPF's ROE is +0.14%, compared to GNCGY's ROE of +0.10%. Regarding short-term risk, ACOPF and GNCGY have similar daily volatility (0.00).Check GNCGY's competition here
ACOPF vs TUFUF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TUFUF has a market cap of 1.5B. Regarding current trading prices, ACOPF is priced at $5.52, while TUFUF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TUFUF's P/E ratio is 12.92. In terms of profitability, ACOPF's ROE is +0.14%, compared to TUFUF's ROE of +0.10%. Regarding short-term risk, ACOPF is less volatile compared to TUFUF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check TUFUF's competition here
ACOPF vs GNCGF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GNCGF has a market cap of 1.5B. Regarding current trading prices, ACOPF is priced at $5.52, while GNCGF trades at $3.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GNCGF's P/E ratio is 0.26. In terms of profitability, ACOPF's ROE is +0.14%, compared to GNCGF's ROE of +0.10%. Regarding short-term risk, ACOPF is less volatile compared to GNCGF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GNCGF's competition here
ACOPF vs FNEVF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FNEVF has a market cap of 1.4B. Regarding current trading prices, ACOPF is priced at $5.52, while FNEVF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FNEVF's P/E ratio is 12.16. In terms of profitability, ACOPF's ROE is +0.14%, compared to FNEVF's ROE of +0.05%. Regarding short-term risk, ACOPF is less volatile compared to FNEVF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FNEVF's competition here
ACOPF vs HLFGY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, HLFGY has a market cap of 1.4B. Regarding current trading prices, ACOPF is priced at $5.52, while HLFGY trades at $15.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas HLFGY's P/E ratio is 24.16. In terms of profitability, ACOPF's ROE is +0.14%, compared to HLFGY's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to HLFGY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check HLFGY's competition here
ACOPF vs NISUY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, NISUY has a market cap of 1.3B. Regarding current trading prices, ACOPF is priced at $5.52, while NISUY trades at $42.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas NISUY's P/E ratio is 10.62. In terms of profitability, ACOPF's ROE is +0.14%, compared to NISUY's ROE of +0.09%. Regarding short-term risk, ACOPF is less volatile compared to NISUY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check NISUY's competition here
ACOPF vs FNEVY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, FNEVY has a market cap of 1.3B. Regarding current trading prices, ACOPF is priced at $5.52, while FNEVY trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas FNEVY's P/E ratio is 11.33. In terms of profitability, ACOPF's ROE is +0.14%, compared to FNEVY's ROE of +0.05%. Regarding short-term risk, ACOPF is less volatile compared to FNEVY. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check FNEVY's competition here
ACOPF vs GUZOF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GUZOF has a market cap of 1.3B. Regarding current trading prices, ACOPF is priced at $5.52, while GUZOF trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GUZOF's P/E ratio is 15.75. In terms of profitability, ACOPF's ROE is +0.14%, compared to GUZOF's ROE of +0.18%. Regarding short-term risk, ACOPF is less volatile compared to GUZOF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check GUZOF's competition here
ACOPF vs VTSYF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, VTSYF has a market cap of 1.3B. Regarding current trading prices, ACOPF is priced at $5.52, while VTSYF trades at $1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas VTSYF's P/E ratio is 39.33. In terms of profitability, ACOPF's ROE is +0.14%, compared to VTSYF's ROE of +0.04%. Regarding short-term risk, ACOPF is less volatile compared to VTSYF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check VTSYF's competition here
ACOPF vs TUFBY Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, TUFBY has a market cap of 1.3B. Regarding current trading prices, ACOPF is priced at $5.52, while TUFBY trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas TUFBY's P/E ratio is 8.70. In terms of profitability, ACOPF's ROE is +0.14%, compared to TUFBY's ROE of +0.10%. Regarding short-term risk, ACOPF and TUFBY have similar daily volatility (0.00).Check TUFBY's competition here
ACOPF vs AKEJF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, AKEJF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $5.52, while AKEJF trades at $35.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas AKEJF's P/E ratio is 28.55. In terms of profitability, ACOPF's ROE is +0.14%, compared to AKEJF's ROE of +0.07%. Regarding short-term risk, ACOPF is less volatile compared to AKEJF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check AKEJF's competition here
ACOPF vs JWLLF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, JWLLF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $5.52, while JWLLF trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas JWLLF's P/E ratio is 27.72. In terms of profitability, ACOPF's ROE is +0.14%, compared to JWLLF's ROE of +0.12%. Regarding short-term risk, ACOPF and JWLLF have similar daily volatility (0.00).Check JWLLF's competition here
ACOPF vs GBFBF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, GBFBF has a market cap of 1.1B. Regarding current trading prices, ACOPF is priced at $5.52, while GBFBF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas GBFBF's P/E ratio is 12.38. In terms of profitability, ACOPF's ROE is +0.14%, compared to GBFBF's ROE of N/A. Regarding short-term risk, ACOPF and GBFBF have similar daily volatility (0.00).Check GBFBF's competition here
ACOPF vs HLTFF Comparison August 2025
ACOPF plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACOPF stands at 4B. In comparison, HLTFF has a market cap of 1B. Regarding current trading prices, ACOPF is priced at $5.52, while HLTFF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACOPF currently has a P/E ratio of 34.50, whereas HLTFF's P/E ratio is 19.22. In terms of profitability, ACOPF's ROE is +0.14%, compared to HLTFF's ROE of +0.13%. Regarding short-term risk, ACOPF is less volatile compared to HLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for ACOPF.Check HLTFF's competition here